JAK2 Exon 14 Deletion in Patients with Chronic Myeloproliferative Neoplasms
Wanlong Ma(Shandong University of Technology), Maher Albitar(Genomic Health (United States))
Cited by 19
Related Papers
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study
|Blood|2002|946
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia
|British Journal of Haematology|2003|80